Abstract

Quantitation of CFTR function in vitro is commonly performed by acutely stimulating then inhibiting ion transport through CFTR and measuring the resulting changes in transepithelial voltage (Vte) and current (ISC). While this technique is suitable for measuring the maximum functional capacity of CFTR, it may not provide an accurate estimate of in vivo CFTR activity. To test if CFTR-mediated ion transport could be measured in the absence of acute CFTR stimulation, primary airway epithelia were analyzed in an Ussing chamber with treatment of amiloride followed by CFTR(inh)-172 without acute activation of CFTR. Non-CF epithelia demonstrated a decrease in Vte and ISC following exposure to CFTR(inh)-172 and in the absence of forskolin/IBMX (F/I); this decrease is interpreted as a measure of spontaneous CFTR activity present in these epithelia. In F508del/F508del CFTR epithelia, F/I-induced changes in Vte and ISC were ~ fourfold increased after treatment with VX-809/VX-770, while the magnitude of spontaneous CFTR activities were only ~ 1.6-fold increased after VX-809/VX-770 treatment. Method-dependent discrepancies in the responses of other CF epithelia to modulator treatments were observed. These results serve as a proof of concept for the analysis of CFTR modulator responses in vitro in the absence of acute CFTR activation. Future studies will determine the usefulness of this approach in the development of novel CFTR modulator therapies.

Highlights

  • The treatment of cystic fibrosis (CF) has been revolutionized by precision medicine approaches

  • In order to determine the amount of spontaneous CFTR activity present in the airway epithelia utilized in the present study, non-CF cultures were mounted in an Ussing chamber and acutely exposed to amiloride followed directly by CFTR(inh)-172

  • All epithelia tested displayed a decrease in transepithelial potential difference/voltage ­(Vte), shortcircuit current ­(ISC), and transepithelial conductance ­(Gte) upon treatment with CFTR(inh)-172 (Fig. 1), suggesting spontaneous CFTR activity is present in these cultures in the absence of induced CFTR activation

Read more

Summary

Introduction

The treatment of cystic fibrosis (CF) has been revolutionized by precision medicine approaches This is evident in the development and use of cystic fibrosis transmembrane conductance regulator (CFTR) m­ odulators[1]. These novel compounds target the dysfunctional protein responsible for CF disease manifestations and enhance CFTRmediated chloride transport in a mutation-specific manner. These compounds have proven to be very effective in the treatment of CF.

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.